ទំព័រដើម › មហារីកដែលរីករាលដាល › មីនេសូតា › Rochester
ការសាកល្បងគ្លីនិកសម្រាប់ មហារីកដែលរីករាលដាល នៅក្នុង Rochester, MN
ការសិក្សាចំនួន 31 សម្រាប់ មហារីកដែលរីករាលដាល កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ Rochester (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
កំពុងជ្រើសរើសដំណាក់កាល 2
- Mayo Clinic in Rochester, Rochester
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
កំពុងជ្រើសរើស
- Mayo Clinic in Rochester, Rochester
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
កំពុងជ្រើសរើសដំណាក់កាល 2
- Mayo Clinic in Rochester, Rochester
PRE-ISPY Phase I/II Oncology Platform Program
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Mayo Clinic Comprehensive Cancer Center, Rochester
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Mayo Clinic, Rochester
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Pharmacy, Rochester
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- និង 3 ទៀត
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Mayo Clinic Rochester, Rochester
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Mayo Clinic Cancer Center, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
កំពុងជ្រើសរើសដំណាក់កាល 2
- Mayo Clinic Rochester, Rochester
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
CREO - Microwave Ablation Feasibility Study
កំពុងជ្រើសរើស
- Mayo Clinic Rochester, Rochester
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- Mayo Clinic in Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
កំពុងជ្រើសរើសដំណាក់កាល 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Mayo Clinic - Rochester, Rochester
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Research Site, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Mayo Clinic, Rochester
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Crinetics Study Site, Rochester
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Mayo Clinic (Minnesota), Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
កំពុងជ្រើសរើសដំណាក់កាល 1
- Mayo Clinic, Rochester
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Mayo Clinic in Rochester, Rochester
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
កំពុងជ្រើសរើស
- Mayo Clinic in Rochester, Rochester
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Mayo Clinic in Rochester, Rochester
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Mayo Clinic Comprehensive Cancer Center, Rochester
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Mayo Clinic Rochester, Rochester
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Mayo Clinic in Rochester, Rochester
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
កំពុងជ្រើសរើសដំណាក់កាល 3
- Mayo Clinic - Rochester, Mn, Rochester
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Mayo Clinic in Minnesota, Rochester
ការសាកល្បងសម្រាប់ មហារីកដែលរីករាលដាល នៅក្នុងទីក្រុងផ្សេងទៀត
- Houston, TXការសិក្សា 104
- New York City, NYការសិក្សា 93
- Nashville, TNការសិក្សា 70
- Boston, MAការសិក្សា 63
- Los Angeles, CAការសិក្សា 57
- St. Louis, MOការសិក្សា 54
- Arlington, VAការសិក្សា 53
- Philadelphia, PAការសិក្សា 46
- Chicago, ILការសិក្សា 45
- San Antonio, TXការសិក្សា 44
- Washington, DCការសិក្សា 43
- Dallas, TXការសិក្សា 42
ការសិក្សាផ្សេងទៀតនៅក្នុង Rochester
- មហារីកទ្រូងការសិក្សា 42
- Non-Small Cell Lung Cancerការសិក្សា 37
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 30
- មហារីកស៊ុតការសិក្សា 29
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 29
- ជំងឺ Multiple Myelomaការសិក្សា 24
- បេះដូងខ្សោយការសិក្សា 22
- មហារីកតូចការសិក្សា 22
- មហារីកតំបក់ការសិក្សា 22
- មហារីកស្រទាប់ស្បែកស្តីការសិក្សា 20
- មហារីកសួតការសិក្សា 20
- ជំងឺលីម្វូស៊ីតប្រចាំការសិក្សា 18
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។